238TiP An update on the CONCORDE study: A phase Ib platform study of DNA damage repair inhibitors (DDRIs) in combination with conventional radiotherapy in NSCLC

Category Primary study
ConferenceEuropean Lung Cancer Congress (ELCC) 2025
Year 2025
This article has no abstract
Epistemonikos ID: a01aceb1a4106af6b0f2db5068399f63671f0472
First added on: Jan 22, 2026